Universe Pharmaceuticals Financials - Benzinga

Universe Pharmaceuticals Inc

UPCNASDAQ

Trade with Public

Trade with Public

$4.36

-0.16-3.65%

Ult. Agg.: Sep 30, 11:34 AM

Panoramica Notizie Previsioni utiliDati finanziariSentiment Confronta Rapporto azionario

Universe Pharmaceuticals Financials

Universe Pharmaceuticals (UPC) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Stock Market Today: Nasdaq 100, S&P 500 Futures Fall as US-Iran Tensions Escalate — DELL, PANW, MDB, AVGO in Focus

U.S. stock futures declined on Wednesday, as the Dow Jones, S&P 500, and Nasdaq 100 indices fell, following Tuesday's lower close.

Rishabh Mishra

Stock Market Today: Nasdaq, Dow S&P 500 Futures Jump As Trump Admin Says US, Iran Will 'Stand Down' For Now— Verizon, HP, Universe Pharmaceuticals In Focus (UPDATED)

U.S. stock futures rose on Monday, as the Dow Jones, Nasdaq 100, and S&P 500 indices rose, following Friday's mixed close.

Rishabh Mishra

Concentrix, AeroVironment And 3 Stocks To Watch Heading Into Monday

U.S. stock futures up, watch Concentrix Corp, Lantheus Holdings, AeroVironment, Viridian Therapeutics, Universe Pharmaceuticals for earnings and news.

Avi Kapoor

Gold Moves Higher; Estée Lauder Shares Slide

Avi Kapoor

Nasdaq Surges Over 1%; Pfizer Earnings Top Estimates

Avi Kapoor

US Stocks Mixed; PepsiCo Posts Downbeat Sales

Avi Kapoor

© 2026 Benzinga | All Rights Reserved